Omada Health, Inc. Common Stock Total Liabilities

Latest as of June 2026: $75.48 Million USD

Omada Health, Inc. Common Stock total liabilities. Based on the latest financial reports, Omada Health, Inc. Common Stock (OMDA) has total liabilities worth $75.48 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Omada Health, Inc. Common Stock asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Omada Health, Inc. Common Stock (2022–2025)

Total liabilities of Omada Health, Inc. Common Stock from 2022 to 2025. This chart illustrates how Omada Health, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.

Omada Health, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of Omada Health, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Sinomach Automobile Co Ltd
SHG:600335
China CN¥27.05 Billion
Bolsas y Mercados Argentinos SA
BA:BYMA
Argentina AR$2.01 Trillion
SINOPEC Engineering (Group) Co. Ltd
F:1NS
Germany €59.40 Billion
North Long Dragon New Materials Technology Co. Ltd. A
SHE:301357
China CN¥89.67 Million
Willdan Group Inc
NASDAQ:WLDN
USA $284.41 Million
City Development Environment Co Ltd
SHE:000885
China CN¥21.52 Billion
Jiangsu Hengshun Vinegar-Industry Co Ltd
SHG:600305
China CN¥791.06 Million
Vietnam Export Import Commercial Joint Stock Bank
VN:EIB
Vietnam ₫247.26 Trillion

Liability Composition Analysis (2022–2025)

This chart breaks down Omada Health, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Omada Health, Inc. Common Stock's balance sheet.

Liquidity & Leverage Metrics

Omada Health, Inc. Common Stock Total Liabilities Ratios Explained

Omada Health, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.23 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Omada Health, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Omada Health, Inc. Common Stock (2022–2025)

The table below shows the annual total liabilities of Omada Health, Inc. Common Stock from 2022 to 2025.

Year Total Liabilities Change
2025-12-31 $75.73 Million -12.21%
2024-12-31 $86.26 Million +13.27%
2023-12-31 $76.16 Million +15.05%
2022-12-31 $66.19 Million --

About Omada Health, Inc. Common Stock

NASDAQ:OMDA USA Health Information Services
Market Cap
$1.14 Billion
Market Cap Rank
#8060 Global
#2411 in USA
Share Price
$18.58
Change (1 day)
+4.09%
52-Week Range
$10.94 - $24.99
All Time High
$26.78
About

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weig… Read more